Osama Sabri Selected Research

Osama Sabri Research Topics

Disease

49	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 11/2003
36	Dementia (Dementias) 01/2022 - 03/2008
22	Cognitive Dysfunction 01/2022 - 03/2008
14	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2022 - 03/2006
10	Obesity 12/2020 - 01/2013
8	Parkinson Disease (Parkinson's Disease) 02/2021 - 05/2004
8	Atrophy 12/2020 - 01/2013
8	Neoplasms (Cancer) 05/2020 - 04/2003
7	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 12/2017 - 06/2010
7	Amyloid Plaque 11/2017 - 04/2006
5	Hodgkin Disease (Hodgkin's Disease) 10/2018 - 08/2006
4	Tauopathies 01/2022 - 01/2019
4	Weight Loss (Weight Reduction) 11/2021 - 01/2016
4	Hypoxia (Hypoxemia) 01/2019 - 04/2003
4	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 06/2011 - 08/2004
3	Disease Progression 01/2022 - 01/2018
3	Lymphoma (Lymphomas) 09/2021 - 01/2021
3	Corticobasal Degeneration 05/2021 - 01/2017
3	Pulmonary Hypertension 01/2021 - 01/2005
3	Neurobehavioral Manifestations 01/2021 - 08/2015
3	Multiple Sclerosis 01/2021 - 05/2014
3	Squamous Cell Carcinoma of Head and Neck 01/2019 - 01/2015
3	Body Weight (Weight, Body) 01/2018 - 01/2016
3	Death (Near-Death Experience) 01/2017 - 06/2016
2	Morbid Obesity 11/2021 - 01/2017
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021 - 01/2021
2	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2021 - 11/2020
2	Fatigue 01/2021 - 01/2020
2	Hyperthyroidism 01/2021 - 12/2016
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 11/2019 - 02/2009
2	Movement Disorders (Movement Disorder) 07/2019 - 08/2008
2	Frontotemporal Dementia (Semantic Dementia) 01/2019 - 05/2015
2	Hyperphagia (Overeating) 06/2017 - 01/2013
2	Parkinsonian Disorders (Parkinsonism) 07/2016 - 01/2013
2	Depressive Disorder (Melancholia) 09/2015 - 08/2009
2	Glioma (Gliomas) 08/2014 - 01/2008
2	Hepatolenticular Degeneration (Wilson's Disease) 04/2012 - 08/2002
2	Thyroid Diseases (Thyroid Disease) 04/2009 - 08/2005
2	Myocardial Infarction 10/2005 - 03/2004
2	Coronary Artery Disease (Coronary Atherosclerosis) 07/2005 - 03/2004
2	Stroke (Strokes) 01/2005 - 03/2004
1	Infections 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 09/2021
1	Delusional Parasitosis 05/2021
1	Tremor (Tremors) 02/2021

Drug/Important Bio-Agent (IBA)

35	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2011
26	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2011
17	4- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA 01/2021 - 01/2011
15	Glucose (Dextrose)FDA LinkGeneric 12/2020 - 01/2005
13	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2021 - 04/2008
9	Serotonin (5 Hydroxytryptamine)IBA 12/2020 - 11/2003
8	Amyloid beta-PeptidesIBA 01/2022 - 04/2006
8	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2021 - 08/2004
8	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2021 - 03/2006
7	Cholinergic Agents (Cholinergics)IBA 01/2022 - 11/2003
7	Pharmaceutical PreparationsIBA 01/2018 - 08/2004
6	N-acetyltalosaminuronic acid (NAT)IBA 11/2021 - 06/2017
6	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 02/2021 - 10/2005
5	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 01/2021 - 01/2018
4	Apolipoproteins E (ApoE)IBA 01/2022 - 05/2011
4	Protein Isoforms (Isoforms)IBA 01/2022 - 01/2019
4	Norepinephrine (Noradrenaline)FDA LinkGeneric 11/2021 - 11/2003
4	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 02/2021 - 02/2009
4	fluoronorchloroepibatidineIBA 01/2021 - 04/2013
4	2beta- carbomethoxy- 3beta- (4- iodophenyl)tropane (Iometopane)IBA 01/2006 - 08/2002
3	tau Proteins (tau Protein)IBA 01/2022 - 01/2019
3	Deoxyglucose (2 Deoxy D glucose)IBA 09/2021 - 10/2005
3	LigandsIBA 01/2021 - 03/2008
3	Biological ProductsIBA 07/2019 - 05/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 01/2019
3	Neurotransmitter Agents (Neurotransmitter)IBA 06/2017 - 11/2003
2	PrionsIBA 01/2022 - 07/2019
2	Cholinergic ReceptorsIBA 01/2022 - 03/2008
2	1'- benzyl- 3- (2- fluoroethyl)- 3H- spiro((2)benzofuran- 1,4'- piperidine)IBA 01/2021 - 05/2020
2	3- amino- 4- (2- dimethylaminomethylphenylsulfanyl)benzonitrileIBA 01/2021 - 12/2020
2	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 01/2013
2	Citalopram FDA LinkGeneric 01/2019 - 01/2006
2	Tumor Suppressor Protein p53IBA 01/2019 - 01/2019
2	ErbB Receptors (EGF Receptor)IBA 01/2019 - 01/2019
2	Indicators and Reagents (Reagents)IBA 07/2017 - 08/2015
2	3- iodo- 2- hydroxy- 6- methoxy- N- ((1- ethyl- 2- pyrrolidinyl)methyl)benzamideIBA 08/2008 - 02/2003
2	cytidylyl-(3'-5')-cytidine (CpC)IBA 04/2008 - 10/2005
2	2-fluoro-3-(2-azetidinylmethoxy)pyridineIBA 03/2008 - 03/2008
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 04/2022
1	antineoplaston A10 (A 10)IBA 01/2022
1	EnzymesIBA 01/2022
1	Yttrium-90IBA 01/2022
1	3- (1,4- diazabicyclo(3.2.2)nonan- 4- yl)- 6- fluorodibenzo(b,d)thiophene 5,5-dioxideIBA 01/2022
1	Anaplastic Lymphoma KinaseIBA 09/2021
1	Valproic Acid (Depakote)FDA LinkGeneric 05/2021

Therapy/Procedure

11	Therapeutics 01/2022 - 07/2005
7	Drug Therapy (Chemotherapy) 01/2021 - 08/2006
2	Deep Brain Stimulation 02/2021 - 07/2008
2	Transplantation 01/2021 - 10/2005
2	Induction Chemotherapy 10/2018 - 01/2017
2	Bariatric Surgery 01/2017 - 01/2016
2	Radiotherapy 01/2017 - 01/2008
1	Arthroplasty 01/2022
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 11/2021